The Center for Nanomedicine
A unique translational nanotechnology enterprise that brings engineers, scientists and clinicians together on the translation of novel drug and gene delivery technologies
Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:
Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus
Find more COVID-19 testing locations on Maryland.gov.
A unique translational nanotechnology enterprise that brings engineers, scientists and clinicians together on the translation of novel drug and gene delivery technologies
A pioneering, collaborative research effort across Johns Hopkins to study and cure vision loss and blindness through regenerative medicine
In support of a highly collaborative, interdisciplinary environment of research resource centers known as the Wilmer Core
Aimed at improving the diagnosis, management and treatment of corneal and external disease problems
Focuses on national and international public health prevention of blinding eye diseases such as diabetic retinopathy, trachoma and glaucoma
Aims to improve the health of people with visual impairments and other types of disabilities
Working to dramatically improve outcomes for those affected by glaucoma through groundbreaking diagnostic and therapeutic methods.
MWEI comprises facilities for confocal and transmission microscopy, as well as imaging of tissue cultures and frozen sections that contribute to research into ocular disorders and allied health problems for those who access its facilities.
Aims to advance the prevention and treatment of neuro-ophthalmic disorders through groundbreaking research.
Focused on the causes and treatments of ocular inflammatory diseases, including uveitis, intraocular inflammation, scleritis and iritis.
Studies the development of blood vessels in the eye and how they change in diseases of the eye.
Currently focused on structures around the eyes and their relation to ocular diseases and orbital trauma, as well as their treatments.
Focuses on detection, management and treatment of pediatric and adult forms of strabismus and amblyopia.
Includes projects and multiple labs engaged in groundbreaking discoveries aimed at transforming the study and treatment of retinal diseases.
A joint venture of Wilmer and the Department of Biomedical Engineering to establish focus in research, education, and industrial development in regenerative medicine
Focused on assessing and enhancing the functional visual abilities of individuals with ultra-low vision.
Speak with someone about making a charitable gift to Wilmer. Please call 410-955-2020.
Download our giving form to mail in your generous donation.